ALGS
Aligos Therapeutics Inc
NASDAQ: ALGS · HEALTHCARE · BIOTECHNOLOGY
$5.99
+0.34% today
Updated 2026-04-30
Market cap
$36.94M
P/E ratio
—
P/S ratio
16.90x
EPS (TTM)
$-2.45
Dividend yield
—
52W range
$4 – $14
Volume
0.2M
Aligos Therapeutics Inc (ALGS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-86.0%
Last 4 quarters
Revenue YoY growth
-73.1%
Most recent quarter
EPS YoY growth
+85.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.5%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-1.91 | +23.2% | $6.86 | $6.98 | +1.7% |
| 2025-11-06 | $-3.04 | -1116.0% | $7.33 | $7.07 | -3.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-2.49 | $-1.91 | +23.2% | $169000.00 | -73.1% |
| 2025-09-30 | $-0.25 | $-3.04 | -1116.0% | $741000.00 | -41.6% |
| 2025-06-30 | $-0.24 | $-1.53 | -537.5% | $965000.00 | -9.0% |
| 2025-03-31 | $-3.15 | $-2.11 | +33.0% | $311000.00 | -68.5% |
| 2024-12-31 | $-3.67 | $-13.10 | -256.9% | $629000.00 | -76.5% |
| 2024-09-30 | $-2.16 | $-3.07 | -42.1% | $1.27M | -60.8% |
| 2024-06-30 | $-0.16 | $0.03 | +118.8% | $1.06M | -84.6% |
| 2024-03-31 | $-0.19 | $-0.22 | -15.8% | $986000.00 | -63.8% |
| 2023-12-31 | $-0.27 | $-0.22 | +18.5% | $2.68M | — |
| 2023-09-30 | $-0.47 | $-0.41 | +12.8% | $3.24M | — |
| 2023-06-30 | $-0.49 | $-0.43 | +12.2% | $6.89M | — |
| 2023-03-31 | $-0.48 | $-0.53 | -10.4% | $2.72M | — |
Frequently asked questions
Has Aligos Therapeutics Inc beaten earnings estimates?
Aligos Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -86.0% over the last 4 quarters.
How does ALGS stock react to earnings?
ALGS stock has moved an average of -0.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Aligos Therapeutics Inc's revenue growth rate?
Aligos Therapeutics Inc reported year-over-year revenue growth of -73.1% in its most recent quarter, with EPS growing +85.4% year-over-year.